local_hospital

CRS Clinical Research Services Management GmbH

Address
lock Available on a paid plan

CRS Clinical Research Services Management GmbH - Early Phase Clinical Research Center

CRS Clinical Research Services Management GmbH is a specialized research facility focused on conducting early-phase clinical trials and pharmacokinetic studies in healthy volunteers and patients with dermatological conditions. The center demonstrates expertise in Phase I first-in-human studies, dose-escalation trials, and complex pharmacology assessments that form the foundation of drug development programs.

  • Dermatological disorders including plaque psoriasis, atopic dermatitis, and chronic pruritus conditions
  • Pharmacokinetic and pharmacodynamic studies evaluating drug-drug interactions and bioavailability
  • First-in-human trials with novel biologics and monoclonal antibodies
  • Reproductive health research including fertility-related investigations

The center's research portfolio spans from basic pharmacokinetic profiling in healthy subjects to sophisticated efficacy trials in patients with moderate-to-severe inflammatory skin conditions. With capabilities ranging from single-dose safety studies to multi-center Phase 3 trials, CRS demonstrates proficiency in evaluating both small molecules and advanced biologic therapies, including anti-IL1RAP monoclonal antibodies and oral kappa opioid receptor agonists for pruritus management.

Site Overview

assignment
35
connected trials
corporate_fare
16
sponsors
science
14
IMPs

Activity Indicator

Last 6 months

8
Trials started
+100% vs previous period.
4
Trials started 6–12 months ago
35
Total trials linked
Highly Active
trending_upGrowing+100%
3
1
3
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 5 of 7 therapeutic areas and 13 of 14 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
11
Sponsors (total)
16
Active sponsors
6

Sponsor Network

Top 6 by active trials.

lock +5 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +5 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 2 161 other sites in Germany

description
Trial volume
35
Outperforms 94% of sites
public
Therapeutic diversity
12areas
Outperforms 97% of sites
groups
Sponsor diversity
16sponsors
Outperforms 92% of sites

Therapeutic Area Benchmark — Germany

Select a therapeutic area to compare against other sites in Germany.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Germany

Market Share

Country: Germany

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in CRS Clinical Research Services Management GmbH

lock Showing 1 of 35 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Comparative Pharmacokinetic Study of Two Survodutide Formulations in Healthy VolunteersBoehringer Ingelheim International GmbHPhase INot RecruitingJul 2025Oct 2025

IMP list

lock Showing 1 of 14 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Jnj-772421132Unknown2023-12-052024-03-22

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.